News & Insights

News

29 Aug 2025

Peel Hunt is delighted to have acted as Joint Bookrunner, Corporate Broker and Joint Financial Adviser to Ondine Biomedical Inc. on its successful £11m capital raise.

1 Jul 2025

New Corporate Client - Ondine Biomedical Inc

10 Apr 2025

New corporate client - PureTech Health plc

18 Jul 2024

£40.5 m Acquisition - GE HealthCare Medical Technology

20 Jun 2024

€30.7m Equity fundraise – Faron Pharmaceuticals

18 Jun 2024

IPO (£35.1 m fund raise) – AOTI

29 Feb 2024

£25.7m Placing and separate Rex Offer – Avacta Group

14 Feb 2024

£8.38m Accelerated Bookbuild Placing of Secondary Shares – hVIVO

8 Jan 2024

New Corporate Client – hVIVO

28 Sep 2023

US$6.1m Equity Fundraise – Shield Therapeutics

20 Sep 2023

New Corporate Client – Avacta Group

4 Sep 2023

£703.1 m Recommended Cash Acquisition - Ergomed

4 Aug 2023

New Corporate Client – PureTech Health

4 May 2023

Mandatory Cash Offer – Shield Therapeutics

13 Dec 2022

£19.0 m Proposed Placing, Subscription and Open Offer – Shield Therapeutics

28 Jan 2022

£80m Placing – Oxford Biomedica

2 Nov 2021

Formal Sale Process - Sensyne Health

29 Oct 2021

New Corporate Client – Sareum Holdings